Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Appointment of Chief Finance Officer (CFO)

 Glenmark Pharmaceuticals Ltd has informed BSE that Mr. Rajesh Desai, Executive Director - IT, Finance & Legal has been with Glenmark for over thirty-three years. During this period, he has been a significant contributor in shaping the growth and sustained success. Mr. Desai is due to retire in July, 2016. He has graciously agreed to an extension until March 31, 2017 to ensure a smooth transition. In addition, Mr. Desai will continue on the Company's Board of Directors....
12-05-2016
Bigul

Board recommends Dividend

 Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2016, inter alia, has recommended Dividend @ 200% i.e. Rs. 2/- per share (face value Re. 1/-) on the Equity Share Capital of the Company for the financial year 2015-2016 subject to the approval of the Shareholders at the ensuing Annual General Meeting.
12-05-2016
Bigul

Announces Q4 & FY16 Results (Standalone & Consolidated), Form A (Standalone & Consolidated), Auditors Report (Standalone & Consolidated), Management Discussion & Analysis and Results Press Release for the period ended March 31, 2016

 Glenmark Pharmaceuticals Ltd has announced the following results for the quarter & year ended March 31, 2016:The Audited Standalone results for the Quarter ended March 31, 2016The Company has posted a net profit of Rs. 5077.58 million for the quarter ended March 31, 2016 as compared to Rs. 6704.30 million for the quarter ended March 31, 2015. Total Income has decreased from Rs. 31577.90 million for the quarter ended March 31, 2015...
12-05-2016
Bigul

Annual report for Glenmark Pharmaceuticals Ltd. for FY-2016
12-05-2016
Bigul

Buy Glenmark with a target of Rs 888: Siddarth Bhamre

 Buy Glenmark Ltd with a target of Rs 888 and a stop loss of Rs 811
10-05-2016
Bigul

Earnings Call

 Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of the details of Earnings Call slated for May 13, 2016,8.30 am - 9.30 am (IST).
09-05-2016
Bigul

Glenmark Pharma's drugs gets tentative ANDA approval

 The approvals are for norethindrone acetate and for adapalene and benzoyl peroxide gel
02-05-2016

Glenmark gets tentative FDA nod for anti-acne Epiduo gel in US

 Epiduo gel recorded sales of around $351.8 million in the year to February, according to IMS Health sales data
29-04-2016
Bigul

FY16 results on May 12, 2016

 Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 12, 2016:1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2016.2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2016....
29-04-2016
Bigul

Glenmark Pharmaceuticals receives tentative ANDA approval for Adapalene and Benzoyl Peroxide Gel, 0.1% / 2.5%

 Glenmark Pharmaceuticals Ltd has informed BSE about a press release dated April 29, 2016 informing "Glenmark Pharmaceuticals receives tentative ANDA approval for Adapalene and Benzoyl Peroxide Gel, 0.1% / 2.5%".
29-04-2016
Next Page
Close

Let's Open Free Demat Account